XMEX
VITROA
Market cap116mUSD
Oct 08, Last price
4.52MXN
1D
0.00%
1Q
-13.74%
Jan 2017
-92.99%
Name
Vitro SAB de CV
Chart & performance
P/E
0.85
P/S
0.39
EPS
0.29
Div yield, %
—
Shrs. gr., 5y
-0.17%
Rev. gr., 5y
-29.85%
Revenues
300m
+5.71%
Net income
138m
P
CFO
163m
+112.81%
Dividend
May 20, 202631.91162 MXN/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Vitro, S.A.B. de C.V., through its subsidiaries, produces, processes, distributes, and markets inorganic chemical products worldwide. The company provides sodium carbonate and bicarbonate, calcium chloride, and sodium chloride. It serves automotive, glass, detergent, water treatment, pharmaceutical, food, oil, road deicing, and livestock sectors. Vitro, S.A.B. de C.V. was founded in 1909 and is based in San Pedro Garza García, Mexico.
Related entities
Subsidiaries (2)
Vitro Automotive Glass LLC
VITRO FLAT GLASS LLC
Key people
Claudio L. Del Valle Cabello
Chief Financial and Administrative Officer, Non-Member Secretary of the Board of Directors · since 2023
Ricardo Flores
Director - Treasury and Finance · since 2024
Carlos Bernal
President of Vitro Automotive Glass
Shlomo Frymerman
President of Vitro Glass Containers
Ricardo Maiz
President of Vitro Architectural Glass
Alfonso Tamez
Chief Human Resource and Continuous Improvement Officer · since 2021
Jorge Cecena Romo
Director - Alcali, Strategic Projects, Sales, Commercial, Exports and Business Development
Director · since 2013
Chairman of the Board, Chief Executive Officer · since 2023
Director · since 2023
Independent Proprietary Director · since 2023
Mario Martin Laborin Gomez
Independent Director · since 2010
Ricardo Martin Bringas
Independent Director · since 2007
Independent Director · since 1998
Headquarters & legal address
Avenida Ricardo Margain Zozaya
Colonia Valle del Campestre
San Pedro Garza Garcia, NLE 66265
MX
Colonia Valle del Campestre
San Pedro Garza Garcia, NLE 66265
MX
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||